CUSIP: 44052TAB7
What is CUSIP 44052TAB7?
CUSIP 44052TAB7 identifies 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 44052TAB7:
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2020 Q3 | $0 | $0 | -$352,716,000 | 0 | |
| 2020 Q2 | $181,474,500 | $352,716,000 | -$251,221,368 | 193.44% | 20 |
| 2020 Q1 | $383,345,200 | $445,715,262 | +$19,776,516 | 116.1% | 32 |
| 2019 Q4 | $359,958,200 | $476,893,298 | -$30,425,539 | 132.55% | 33 |
| 2019 Q3 | $367,417,200 | $427,997,905 | +$7,445,307 | 116.6% | 32 |
| 2019 Q2 | $361,581,200 | $400,747,000 | +$33,026,101 | 111.02% | 32 |
| 2019 Q1 | $331,544,000 | $375,896,991 | -$18,298,145 | 113.46% | 30 |
| 2018 Q4 | $349,698,000 | $347,637,000 | -$30,978,162 | 99.6% | 26 |
| 2018 Q3 | $379,972,000 | $382,341,000 | +$3,808,450 | 100.6% | 24 |
| 2018 Q2 | $377,098,000 | $361,615,000 | +$880,601 | 95.8% | 30 |
| 2018 Q1 | $376,464,592 | $347,184,000 | +$13,930,916 | 92.0% | 35 |
| 2017 Q4 | $361,263,910 | $336,560,860 | +$14,582,854 | 93.0% | 31 |
| 2017 Q3 | $346,115,000 | $313,051,816 | +$10,662,513 | 90.32% | 31 |
| 2017 Q2 | $344,131,500 | $299,925,725 | -$28,608,102 | 86.25% | 29 |
| 2017 Q1 | $373,602,000 | $342,563,846 | -$25,485,556 | 91.51% | 25 |
| 2016 Q4 | $402,419,720 | $386,194,906 | -$866,733 | 95.14% | 28 |
| 2016 Q3 | $403,178,000 | $390,684,886 | -$5,972,301 | 96.72% | 27 |
| 2016 Q2 | $408,645,440 | $378,634,000 | +$3,608,363 | 91.12% | 34 |
| 2016 Q1 | $407,952,000 | $347,863,000 | +$347,863,000 | 85.32% | 33 |